Speeding Up Antibody Discovery for Infectious Disease Tasked with an ambitious goal from the Defense Advanced Research Projects Agency (DARPA) to develop a rapid response to help medical workers fight viral diseases in the field, Vanderbilt University Medical Center has already reduced the time to develop antibodies significantly. High-throughput, synthetic genes from Twist Bioscience have allowed the lab to expedite this process. CASE STUDY OCTOBER 2018Vanderbilt University Medical Center (VUMC) is recognized as a world leader in developing monoclonal antibodies for the treatment of infectious disease. The institution has isolated human monoclonal antibodies for many pathogenic viruses while pioneering the design of new antibody-based disease therapeutics and vaccines, man

Join for free to read